Claudia De Angelis

Azienda Ospedaliero-Universitaria Careggi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial”.

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) Trial

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.11.012

N/A

0.413DataRank · unranked

10 citations

Yaohua Ma, Claudia De Angelis, François Richard, Christine Desmedt, Ahmad Awada +7 more

170P β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled on the NCCTG-N9831 (Alliance) trial

Annals of Oncology(2020)10.1016/j.annonc.2020.08.292

N/A

0DataRank · unranked

1 citations

Y. Ma, Claudia De Angelis, François Richard, Christine Desmedt, Ahmad Awada +7 more